Trevor R.F. Smith
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- Biotechnology top 10%
- Microbial Inactivation Methods
- Transgenic Plants and Applications
Papers in
- Immunology 17
- Immunotherapy and Immune Responses 10
- Toxin Mechanisms and Immunotoxins 6
-
- SARS-CoV-2 and COVID-19 Research 6
- Viral gastroenteritis research and epidemiology 5
- Co-authors
- Kate E. Broderick (24 shared papers)Katherine Schultheis (15 shared papers)Vipin Kumar (1 shared paper)Niranjan Y. Sardesai (9 shared papers)Janess Mendoza (6 shared papers)Dinah Amante (5 shared papers)David B. Weiner (14 shared papers)Kar Muthumani (8 shared papers)
- Journals
- Human Vaccines & Immunotherapeutics (5 papers)Frontiers in Immunology (4 papers)Human Gene Therapy Methods (3 papers)Vaccine (3 papers)npj Vaccines (2 papers)
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Trevor R.F. Smith
31 papers receiving 511 citations
Peers
Comparison fields: 5 of 71
- Infectious Diseases 189
- Biotechnology 79
- Immunology 183
- Animal Science and Zoology 35
- Virology 15
Countries citing papers authored by Trevor R.F. Smith
This map shows the geographic impact of Trevor R.F. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trevor R.F. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trevor R.F. Smith more than expected).
Fields of papers citing papers by Trevor R.F. Smith
This network shows the impact of papers produced by Trevor R.F. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trevor R.F. Smith. The network helps show where Trevor R.F. Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Trevor R.F. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Specific control of immunity by regulatory CD8 T cells. | 2005 | 57 |
| 2 | 2018 | 50 | |
| 3 | 2020 | 42 | |
| 4 | 2020 | 40 | |
| 5 | 2017 | 38 | |
| 6 | 2015 | 35 | |
| 7 | 2013 | 34 | |
| 8 | 2014 | 25 | |
| 9 | 2018 | 25 | |
| 10 | 2017 | 21 | |
| 11 | 2017 | 14 | |
| 12 | 2023 | 13 | |
| 13 | 2016 | 13 | |
| 14 | 2017 | 13 | |
| 15 | 2013 | 12 | |
| 16 | 2022 | 12 | |
| 17 | 2020 | 10 | |
| 18 | 2014 | 9 | |
| 19 | 2019 | 8 | |
| 20 | 2020 | 8 |
About Trevor R.F. Smith
Trevor R.F. Smith is a scholar working on Immunology, Infectious Diseases, Biotechnology, Epidemiology and Genetics, having authored 33 papers that have together received 520 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), Microbial Inactivation Methods (9 papers), Transgenic Plants and Applications (7 papers), Virus-based gene therapy research (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Toxin Mechanisms and Immunotoxins (6 papers), Viral gastroenteritis research and epidemiology (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Infectious Diseases (189 citations), Biotechnology (79 citations), Immunology (183 citations), Animal Science and Zoology (35 citations) and Virology (15 citations). Trevor R.F. Smith has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Kate E. Broderick, Katherine Schultheis, Vipin Kumar, Niranjan Y. Sardesai, Janess Mendoza, Dinah Amante, David B. Weiner, Kar Muthumani, Laurent Humeau and Ami Patel. Their work appears in journals such as Human Vaccines & Immunotherapeutics, Frontiers in Immunology, Human Gene Therapy Methods, Vaccine and npj Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.